Clinical trial

International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device

NCT02656329

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Iobenguane I -123 Injection Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Implantable Cardioverter Defibrillator Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Thyroid blocking Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Iobenguane I -123 Injection Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Implantable Cardioverter Defibrillator Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2015-12-30

PhasePHASE3

Conditions

Heart Failureverified · MONDO: heart failure

Interventions

Iobenguane I -123 InjectionDRUG

Implantable Cardioverter DefibrillatorDEVICE

Thyroid blockingDRUG

Iobenguane I -123 InjectionDRUG

Implantable Cardioverter DefibrillatorDEVICE

Sponsors & collaborators

GE Healthcarelead sponsor

Advanced Clinical, LLCcollaborator

TFScollaborator

H2O Clinical LLCcollaborator

AG Mednetcollaborator

ICON plccollaborator

ABX CROcollaborator

TransPerfectcollaborator

Mapped research locations

BudapestHungary5 MadridSpain2 TampaFlorida, United States2 WarsawPoland2 PragueCzechia2 ToulouseFrance2 BuffaloNew York, United States2 AmsterdamNetherlands2 BrnoCzechia2 HoustonTexas, United States1 BostonMassachusetts, United States1 ChicagoIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02656329 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.